Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (The SUN Study)

Sexually Transmitted Diseases

Volumn 38, Issue 4, 2011, Pages 253-259

  Kojic, Erna Milunka ^a   Cu Uvin, Susan ^a   Conley, Lois ^b   Bush, Tim ^b   Onyekwuluje, Juanita ^c   Swan, David C ^c   Unger, Elizabeth R ^c   Henry, Keith ^d   Hammer, John H ^e   Overton, Edgar T ^f   Darragh, Teresa M ^g   Palefsky, Joel M ^g   Vellozzi, Claudia ^b   Patel, Pragna ^b   Brooks, John T ^b  

^a BROWN UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

^e ROSE MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANUS DISEASE; ANUS INTERCOURSE; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PROSPECTIVE STUDY; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY;

ADULT; ANAL CANAL; ANUS DISEASES; CERVIX UTERI; COHORT STUDIES; CYTOLOGICAL TECHNIQUES; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 79953180522     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181f70253     Document Type: Article

References (43)

1. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-265. (Pubitemid 34293391)
2. Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 2003; 89:101-105. (Pubitemid 36897943)
3. Melbye M, Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 1991; 338:657-659.
4. Tachezy R, Jirasek T, Salakova M, et al. Human papillomavirus infection and tumours of the anal canal: Correlation of histology, PCR detection in paraffin sections and serology. APMIS 2007; 115:195-203. (Pubitemid 46426654)
5. Ahdieh L, Klein RS, Burk R, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human im-munodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001; 184:682-690. (Pubitemid 32826418)
6. Duerr A, Kieke B, Warren D, et al. Human papillomavirusassociated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol 2001; 184:584-590. (Pubitemid 32234970)
7. Holly EA, Ralston ML, Darragh TM, et al. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001; 93:843-849. (Pubitemid 32586612)
8. Sun XW, Kuhn L, Ellerbrock TV, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997; 337:1343-1349. (Pubitemid 27467768)
9. Ahdieh-Grant L, Li R, Levine AM, et al. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst 2004; 96:1070-1076. (Pubitemid 39172408)
10. Heard I, Schmitz V, Costagliola D, et al. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998; 12:1459-1464. (Pubitemid 28369645)
11. Heard I, Tassie JM, Kazatchkine MD, et al. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 2002; 16:1799-1802.
12. Lillo FB, Ferrari D, Veglia F, et al. Human papillomavirus infection and associated cervical disease in human immunodefi-ciency virus-infected women: Effect of highly active antiretroviral therapy. J Infect Dis 2001; 184:547-551. (Pubitemid 32783544)
13. Minkoff H, Ahdieh L, Massad LS, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001; 15:2157-2164. (Pubitemid 33101823)
14. Moore AL, Sabin CA, Madge S, et al. Highly active antiretroviral therapy and cervical intraepithelial neoplasia. AIDS 2002; 16: 927-929. (Pubitemid 34409018)
15. Schuman P, Ohmit SE, Klein RS, et al. Longitudinal study of cervical squamous intraepithelial lesions in human immunodefi-ciency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003; 188:128-136. (Pubitemid 36829752)
16. Uberti-Foppa C, Ferrari D, Lodini S, et al. Long-term effect of highly active antiretroviral therapy on cervical lesions in HIVpositive women. AIDS 2003; 17:2136-2138. (Pubitemid 37297168)
17. D'Souza G, Wiley DJ, Li X, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008; 48:491-499.
18. Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19:1407-1414. (Pubitemid 41800677)
19. Piketty C, Darragh TM, Heard I, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31:96-99. (Pubitemid 38141642)
20. Durante AJ, Williams AB, Da Costa M, et al. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol Biomarkers Prev 2003; 12:638-642. (Pubitemid 36899844)
21. Vellozzi C, Brooks JT, Bush TJ, et al. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study). Am J Epidemiol 2009; 169:642-552.
22. Habis AH, Vernon SD, Lee DR, et al. Molecular quality of exfoliated cervical cells: Implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev 2004; 13:492-496. (Pubitemid 38737478)
23. Heard I, Palefsky JM, Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004; 9:13-22. (Pubitemid 38313943)
24. Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001; 183:383-391. (Pubitemid 32105597)
25. Jamieson DJ, Duerr A, Burk R, et al. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol 2002; 186:21-27. (Pubitemid 34093734)
26. Luque AE, Jabeen M, Messing S, et al. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis 2006; 194:428-434. (Pubitemid 44162653)
27. Viscidi RP, Ahdieh-Grant L, Clayman B, et al. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis 2003; 187:194-205. (Pubitemid 36132633)
28. Monsonego J, Pollini G, Evrard MJ, et al. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear. Int J STD AIDS 2008; 19:385-392.
29. Williams AB, Darragh TM, Vranizan K, et al. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994; 83:205-211. (Pubitemid 24043289)
30. Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999; 91:226-236. (Pubitemid 29090991)
31. Vaccarella S, Herrero R, Snijders PJ, et al. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol 2008; 37:536-546. (Pubitemid 351804006)
32. Minkoff H, Feldman JG, Strickler HD, et al. Relationship between smoking and human papillomavirus infections in HIVinfected and-uninfected women. J Infect Dis 2004; 189:1821-1828. (Pubitemid 38657218)
33. Munoz N, Mendez F, Posso H, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004; 190:2077-2087. (Pubitemid 39636354)
34. Sellors JW, Karwalajtys TL, Kaczorowski J, et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003; 168:421-425. (Pubitemid 36255727)
35. Abramowitz L, Benabderrahmane D, Ravaud P, et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: Prevalence and associated factors. AIDS 2007; 21:1457-1465. (Pubitemid 46988006)
36. Clifford GM, Goncalves MA, Franceschi S. Human papillomavirus types among women infected with HIV: A meta-analysis. AIDS 2006; 20:2337-2344. (Pubitemid 44789536)
37. Strickler HD, Palefsky JM, Shah KV, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virusseropositive women. J Natl Cancer Inst 2003; 95:1062-1071. (Pubitemid 36950110)
38. Palefsky JM, Holly EA, Hogeboom CJ, et al. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:415-422.
39. Papaconstantinou HT, Lee AJ, Simmang CL, et al. Screening methods for high-grade dysplasia in patients with anal condyloma. J Surg Res 2005; 127:8-13. (Pubitemid 40814624)
40. Arbyn M, Bergeron C, Klinkhamer P, et al. Liquid compared with conventional cervical cytology: A systematic review and metaanalysis. Obstet Gynecol 2008; 111:167-177.
41. Hessol NA, Holly EA, Efird JT, et al. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIVuninfected women. AIDS 2009; 23:59-70.
42. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92:1500-1510.
43. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148:728-736. (Pubitemid 351717418)